Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Sight Sciences, Inc.
Insider Taylor Brenton of Sight Sciences, Inc. filed an SEC Form 4 on October 5, 2026, reporting a change in beneficial ownership of company securities as of October 2, 2026. This filing serves to provide transparency regarding executive stock holdings.…more
Sight Sciences, Inc.
Insider Alison Bauerlein of Sight Sciences, Inc. filed a Form 4 report on October 5, 2026, disclosing changes in beneficial ownership of securities effective as of October 2, 2026.…more
Sight Sciences, Inc.
Insider James Rodberg of Sight Sciences, Inc. reported a change in beneficial ownership of company securities as of October 2, 2026. This filing serves as a Form 4 statement regarding the executive's stock holdings.…more
21 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
Sight Sciences to Report Q3 2026 Financial Results on Nov 4
Sight Sciences announced it will release its financial results for the third quarter of 2026 after the market closes on November 4, 2026. Management will host a conference call to discuss the company's quarterly performance and business outlook.…more
●●●●●●●● ●●●●● ●●●●●●
Sight Sciences announced the commercial availability of its new OMNI Ultra surgical system, which will be showcased at the upcoming American Academy of Ophthalmology annual meeting. While the device offers enhanced procedural flexibility for glaucoma treatment, the company did not disclose specific financial impacts or sales targets.…more
●●●●●●●● ●●●●● ●●●●●●
Sight Sciences announced it will participate in the upcoming Morgan Stanley Global Healthcare Conference on September 15. Management will present the company's latest developments, with a live webcast available for investors on their website.…more
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.